Recro Pharma News (NASDAQ:REPH)

Add to My Stocks
$7.5 $0.09 (1.21%) REPH stock closing price Sep 19, 2018 (Closing)
Recro Pharma Announces Commercial Team Additions   by Globe Newswire on Mar 02, 2018
Recro Pharma Reports Year End 2017 Financial Results   by Globe Newswire on Feb 27, 2018
Recro Pharma Announces PDUFA Date for IV Meloxicam 30mg   by Globe Newswire on Oct 05, 2017
Recro Pharma Reports Inducement Grants for New Staff   by Globe Newswire on Jun 15, 2017

REPH Industry Peers

Company Price Change (%)
Shandong Luoxin (SLUXY)110 (0%)
Mediwound (MDWD)6.40.08 (1.23%)
Trevena (TRVN)1.630.02 (1.21%)
Pernix Therapeutics (PTX)0.850.05 (5.56%)
Acelrx Pharma (ACRX)3.70.05 (1.33%)
Ibio (IBIO)0.90.03 (3.45%)
Albany Molecular Research (AMRI)21.740 (0%)

Top Stock Gainers

show top losers
CompanyPriceChange (%)
MOLECULAR TEMPL (MTEM)6.252.15 (52.44%)
Empresa Distribuidora (EDN)25.173.61 (16.74%)
BBVA Banco Frances (BFR)11.091.49 (15.52%)
HUAZHU GROUP (HTHT)31.074 (14.78%)
Ceragon Networks (CRNT)3.170.37 (13.21%)
Huttig Building Products (HBP)5.470.55 (11.18%)
Mechel PAO (MTL)2.920.29 (11.03%)
Top gainers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 20, 2018
CompanyPriceChange (%)
Copart (CPRT)55.588.59 (13.39%)
Lifevantage (LFVN)10.591.61 (13.2%)
Siebert Financial (SIEB)14.381.94 (11.89%)
Radcom (RDCM)12.551.45 (10.36%)
Fossil (FOSL)22.182.23 (9.14%)
Vince Holding (VNCE)14.881.3 (8.03%)
Medifast (MED)207.9918.16 (8.03%)
Top losers from NASDAQ & NYSE ( Above $100M Market Cap )
* As of Sep 20, 2018